Latest Entrainment Stories
Data presented at ENDO 2013, the Endocrine Society's 95th Annual Meeting WASHINGTON, June 17, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) presented additional data today at ENDO 2013, the Endocrine Society's 95(th) Annual Meeting, demonstrating that tasimelteon can entrain (synchronize) both melatonin and cortisol rhythms. This effect further confirms tasimelteon's potential to reset the master body clock and address the circadian desynchrony which is...
Data presented as a late breaking abstract at SLEEP 2013, the 27th Annual Meeting of Associated Professional Sleep Societies WASHINGTON, June 5, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) presented additional entrainment and patient-level clinical data at SLEEP 2013, the 27th Annual Meeting of Associated Professional Sleep Societies in Baltimore, from its SET (Safety and Efficacy of Tasimelteon) and RESET (Randomized-withdrawal study of the Efficacy and...
WASHINGTON, May 31, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (VANDA) (NASDAQ: VNDA) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tasimelteon, a circadian regulator. Vanda is seeking FDA approval of tasimelteon for the treatment of Non-24-Hour Disorder (Non-24) in the totally blind. Tasimelteon was developed to address a significant unmet medical need, the treatment of Non-24, for which there are currently no...
-- Data to be presented at SLEEP 2013 27th Annual Meeting of the Associated Professional Sleep Societies and the Endocrine Society's 95th Annual Meeting WASHINGTON, May 30, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (VANDA) (NASDAQ: VNDA) today announced that data from the Phase III studies of tasimelteon in Non-24-Hour Disorder (Non-24) will be presented at SLEEP 2013, the 27th Annual Meeting of the Associated Professional Sleep Societies, LLC being held from June 1, 2013...
Brett Smith for redOrbit.com - Your Universe Online A new study on glowing bacteria found within Hawaiian bobtail squid could change the way scientists look at symbiotic microorganisms. The study, which was recently published in the journal mBio, showed the Vibrio fischeri bacteria in the squid’s light organ not only camouflage the animal at night – the bacteria also influence a gene that entrains, or synchronizes, the cephalopod’s circadian rhythms. "To our knowledge, this is...
WASHINGTON, Jan. 23, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (NASDAQ: VNDA), today announced positive results for the second Phase III study of tasimelteon for the treatment of Non-24-Hour Disorder (Non-24). The RESET study (Randomized-withdrawal study of the Efficacy and Safety of Tasimelteon to treat Non-24-Hour Disorder), demonstrated the maintenance effect of 20mg of tasimelteon to entrain melatonin and cortisol circadian rhythms in individuals with Non-24....
WASHINGTON, Dec. 18, 2012 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) today announced positive results from the SET (Safety and Efficacy of Tasimelteon) Phase III study, evaluating tasimelteon, a circadian regulator for the treatment of Non-24-Hour Disorder (Non-24). Tasimelteon succeeded in the primary endpoint of Entrainment of the melatonin (aMT6s) rhythm as compared to placebo. Additionally, tasimelteon demonstrated significant improvements across a number of...
WASHINGTON, Oct. 15, 2012 /PRNewswire/ -- Vanda Pharmaceuticals (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, reported today that tasimelteon has been shown for the first time to restore daily cortisol rhythms in totally blind patients suffering from Non-24-Hour Disorder (Non-24). Tasimelteon was previously reported to entrain the 24-hour rhythm of melatonin secretion...
SAN FRANCISCO, Oct. 3, 2012 /PRNewswire/ -- Mickey Hart, Grateful Dead percussionist, and neurologist Adam Gazzaley, M.D., Ph.D., professor at the University of California San Francisco made history by becoming the first to sonify and visualize brain activity in real time in front of a live audience. The two did so at the closing session of Life @50+, the AARP National Event & Expo in New Orleans on September 22(nd). To see footage from the event, go to...
Michael Landgraf and Fred Williams of MindMachines.com respond to letters to the editor about controversy regarding the use of light and sound machines in classrooms to boost education performance in US public and private schools. Los Angeles, CA (PRWEB) September 22, 2012 Representatives of MindMachines.com, Michael Landgraf and Fred Willaims respond to letters to the editor at mindmachines.com regarding the use of light and sound machines in classrooms to boost education performance in...
